Profil
Chih Huang Ho is currently the Director at Long Dian Marine Biotechnology Co., Ltd. and the Principal at Pac-Link Management Corp., Pac-Link BioVenture Fund I, Sheng Yang Venture Capital Co., Ltd., and Sheng Yang Management Consultants Co., Ltd. Previously, Dr. Ho held positions as the Director at Orgchem Technologies, Inc., Innova Vision Inc., Phalanx Biotech Group, Inc. (Taiwan), Health Ever Biotech Co., Ltd., Lumosa Therapeutics Co., Ltd., and Steminent Biotherapeutics, Inc. Dr. Ho also served as a Member-Supervisory Board at TWi Pharmaceuticals, Inc. from 2012 to 2013.
Dr. Ho holds a doctorate degree from Rice University, a graduate degree from Texas Tech University, and an undergraduate degree from National Taiwan University.
Postes actifs de Chih Huang Ho
| Sociétés | Poste | Début |
|---|---|---|
Pac-Link Management Corp.
Pac-Link Management Corp. Investment ManagersFinance PAC-LINK is an active manager which invests in early, expansion, and late-stage companies in a range of sectors including automotive, life sciences, semiconductors, optical electronic, communication and software. Their geographic focus is on Greater China and North America. The firm aims to construct a balanced portfolio of early, expansion, and late-stage investments, seeking to invest USD 2-10 million in companies with transparent financial disclosure and down side protection, positive revenue trends, proven products, a seasoned management team with demonstrated market expertise and unique technologies, products or business models. PAC-LINK partners with their investee companies to create value. They prefer to invest in vertically integrated businesses in order to improve their exit position, typically exiting via IPOs and strategic acquisitions. | Director of Investments | - |
Pac-Link BioVenture Fund I
Pac-Link BioVenture Fund I Investment ManagersFinance Acts as Venture Capital Fund | Directeur/Membre du Conseil | 03/11/2010 |
Sheng Yang Management Consultants Co., Ltd. | Directeur Général | - |
Sheng Yang Venture Capital Co., Ltd. | Directeur Général | - |
Long Dian Marine Biotechnology Co., Ltd. | Directeur/Membre du Conseil | - |
Anciens postes connus de Chih Huang Ho
| Sociétés | Poste | Fin |
|---|---|---|
| TWI PHARMACEUTICALS INC | Directeur/Membre du Conseil | 07/06/2013 |
Orgchem Technologies, Inc.
Orgchem Technologies, Inc. Chemicals: SpecialtyProcess Industries Manufactures organic synthesis materials | Directeur/Membre du Conseil | - |
Innova Vision Inc.
Innova Vision Inc. Medical SpecialtiesHealth Technology Manufactures medical equipment | Directeur/Membre du Conseil | - |
| STEMINENT BIOTHERAPEUTICS INC. | Directeur/Membre du Conseil | - |
| ░░░░░░░ ░░░░░░░ ░░░░░░ ░░░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░ | - |
Formation de Chih Huang Ho
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
Rice University
Rice University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Texas Tech University
Texas Tech University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Taiwan University
National Taiwan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pac-Link Management Corp.
Pac-Link Management Corp. Investment ManagersFinance PAC-LINK is an active manager which invests in early, expansion, and late-stage companies in a range of sectors including automotive, life sciences, semiconductors, optical electronic, communication and software. Their geographic focus is on Greater China and North America. The firm aims to construct a balanced portfolio of early, expansion, and late-stage investments, seeking to invest USD 2-10 million in companies with transparent financial disclosure and down side protection, positive revenue trends, proven products, a seasoned management team with demonstrated market expertise and unique technologies, products or business models. PAC-LINK partners with their investee companies to create value. They prefer to invest in vertically integrated businesses in order to improve their exit position, typically exiting via IPOs and strategic acquisitions. | Finance |
Orgchem Technologies, Inc.
Orgchem Technologies, Inc. Chemicals: SpecialtyProcess Industries Manufactures organic synthesis materials | Process Industries |
Pac-Link BioVenture Fund I
Pac-Link BioVenture Fund I Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Innova Vision Inc.
Innova Vision Inc. Medical SpecialtiesHealth Technology Manufactures medical equipment | Health Technology |
Phalanx Biotech Group, Inc. (Taiwan)
Phalanx Biotech Group, Inc. (Taiwan) BiotechnologyHealth Technology Operates as biotechnology company which develops genetic testing and analysis technologies | Health Technology |
Sheng Yang Venture Capital Co., Ltd. | |
Sheng Yang Management Consultants Co., Ltd. | |
TWi Pharmaceuticals, Inc.
TWi Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Health Ever Bio-Tech Co., Ltd.
Health Ever Bio-Tech Co., Ltd. BiotechnologyHealth Technology Engages in research and development of botanical drugs | Health Technology |
Lumosa Therapeutics Co., Ltd.
Lumosa Therapeutics Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in new drug development | Health Technology |
Steminent Biotherapeutics, Inc.
Steminent Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of stem cell drugs and technology for neurodegenerative disorders | Health Technology |
Long Dian Marine Biotechnology Co., Ltd. |
















